Sun Pharma Advanced Research Company Limited (NSE:SPARC) — Market Cap & Net Worth

$502.01 Million USD · Rs46.42 Billion INR · Rank #12516

Market Cap & Net Worth: Sun Pharma Advanced Research Company Limited (SPARC)

Sun Pharma Advanced Research Company Limited (NSE:SPARC) has a market capitalization of $502.01 Million (Rs46.42 Billion) as of May 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #12516 globally and #593 in its home market, demonstrating a -0.35% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sun Pharma Advanced Research Company Limited's stock price Rs143.04 by its total outstanding shares 324521588 (324.52 Million). Analyse SPARC operating cash flow to see how efficiently the company converts income to cash.

Sun Pharma Advanced Research Company Limited Market Cap History: 2015 to 2026

Sun Pharma Advanced Research Company Limited's market capitalization history from 2015 to 2026. Data shows change from $1.19 Billion to $502.01 Million (-8.98% CAGR).

Index Memberships

Sun Pharma Advanced Research Company Limited is a constituent of 4 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NIFTY 500 NIFTY500	$3.11 Trillion	0.02%	#386 of 500
NIFTY MIDSMALLCAP 400 NIFTYMIDSML400	$1.11 Trillion	0.05%	#298 of 400
NIFTY TOTAL MARKET NIFTYTOTALMKT	$3.20 Trillion	0.02%	#462 of 750
NIFTY SMALLCAP 250 NISM250	$375.15 Billion	0.13%	#198 of 250

Weight: Sun Pharma Advanced Research Company Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Sun Pharma Advanced Research Company Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Sun Pharma Advanced Research Company Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

0.66x

Sun Pharma Advanced Research Company Limited's market cap is 0.66 times its annual revenue

Industry average: 1.04x Lower than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$1.07 Billion	$1.61 Billion	-$699.92 Million	0.66x	N/A
2017	$1.78 Billion	$1.81 Billion	-$1.20 Billion	0.98x	N/A
2018	$659.98 Million	$782.59 Million	-$1.97 Billion	0.84x	N/A
2019	$548.20 Million	$1.83 Billion	-$1.45 Billion	0.30x	N/A
2020	$679.98 Million	$768.14 Million	-$3.12 Billion	0.89x	N/A
2021	$980.23 Million	$2.53 Billion	-$1.51 Billion	0.39x	N/A
2022	$732.10 Million	$1.37 Billion	-$2.03 Billion	0.53x	N/A
2023	$1.01 Billion	$2.39 Billion	-$2.23 Billion	0.42x	N/A
2024	$703.85 Million	$755.45 Million	-$3.87 Billion	0.93x	N/A
2025	$471.86 Million	$717.70 Million	-$3.43 Billion	0.66x	N/A

Competitor Companies of SPARC by Market Capitalization

Companies near Sun Pharma Advanced Research Company Limited in the global market cap rankings as of May 4, 2026.

Key companies related to Sun Pharma Advanced Research Company Limited by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#499	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#525	Zoetis Inc	NYSE:ZTS	$50.31 Billion	$114.16
#526	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$50.29 Billion	CN¥53.88
#572	GALDERMA GROUP AG	NYSE:GALDY	$45.88 Billion	$42.15

Sun Pharma Advanced Research Company Limited Historical Marketcap From 2015 to 2026

Between 2015 and today, Sun Pharma Advanced Research Company Limited's market cap moved from $1.19 Billion to $ 502.01 Million, with a yearly change of -8.98%.

Year	Market Cap	Change (%)
2026	Rs502.01 Million	+6.39%
2025	Rs471.86 Million	-32.96%
2024	Rs703.85 Million	-30.07%
2023	Rs1.01 Billion	+37.49%
2022	Rs732.10 Million	-25.31%
2021	Rs980.23 Million	+44.15%
2020	Rs679.98 Million	+24.04%
2019	Rs548.20 Million	-16.94%
2018	Rs659.98 Million	-62.96%
2017	Rs1.78 Billion	+66.57%
2016	Rs1.07 Billion	-10.29%
2015	Rs1.19 Billion	--

End of Day Market Cap According to Different Sources

On May 4th, 2026 the market cap of Sun Pharma Advanced Research Company Limited was reported to be:

Source	Market Cap
Yahoo Finance	$502.01 Million USD
MoneyControl	$502.01 Million USD
MarketWatch	$502.01 Million USD
marketcap.company	$502.01 Million USD
Reuters	$502.01 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Sun Pharma Advanced Research Company Limited

NSE:SPARC India Drug Manufacturers - Specialty & Generic

Market Cap

$502.01 Million

Rs46.42 Billion INR

Market Cap Rank

#12516 Global

#593 in India

Share Price

Rs143.04

Change (1 day)

-3.72%

52-Week Range

Rs108.71 - Rs198.54

All Time High

Rs519.35